WHO ICTRP trial

Primary dysmenorrhea is a menstrual pain without pathology, womens quality of…

CTRI/2024/11/077106 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2024/11/077106
Public title Primary dysmenorrhea is a menstrual pain without pathology, womens quality of life affected.treatments like painkillers have limitations. This study explores Viburnum opulus, as a anti-spasmodic effects in treating primary dysmenorrhea
Scientific title To evaluate the efficacy of viburnum opulus in managing primary dysmenorrhoea and enhancing quality of life in young females by using WAaLIDD score - NIL
Primary sponsor Dr khushbu j mahyavanshi
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2/ Phase 3
Countries India
Conditions Health Condition 1: N944- Primary dysmenorrhea
Interventions Intervention1: viburnum opulus: According to susceptiblity of the patient i will select the potency,mother tincture,30,200 bd ,3-4 days for 5 month Control Intervention1: Nil: Nil
Registration date Nov 20, 2024
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations